These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 35711437)

  • 1. Comprehensive Analysis of a Cancer-Immunity Cycle-Based Signature for Predicting Prognosis and Immunotherapy Response in Patients With Colorectal Cancer.
    Hou Y; Zhang R; Zong J; Wang W; Zhou M; Yan Z; Li T; Gan W; Lv S; Zeng Z; Yang M
    Front Immunol; 2022; 13():892512. PubMed ID: 35711437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational identification and clinical validation of a novel risk signature based on coagulation-related lncRNAs for predicting prognosis, immunotherapy response, and chemosensitivity in colorectal cancer patients.
    Zhang F; Zhang R; Zong J; Hou Y; Zhou M; Yan Z; Li T; Gan W; Lv S; Yang L; Zeng Z; Zhao W; Yang M
    Front Immunol; 2023; 14():1279789. PubMed ID: 37928532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.
    Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z
    Front Immunol; 2022; 13():951455. PubMed ID: 36189298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing an m5C regulator-mediated RNA methylation modification signature to predict prognosis and immunotherapy efficacy in rectal cancer.
    Zhang R; Gan W; Zong J; Hou Y; Zhou M; Yan Z; Li T; Lv S; Zeng Z; Wang W; Zhang F; Yang M
    Front Immunol; 2023; 14():1054700. PubMed ID: 36911744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of a TNF Family-Based Signature for Predicting Prognosis, Tumor Immune Characteristics, and Immunotherapy Response in Colorectal Cancer Patients.
    Xiao Z; Nie K; Han T; Cheng L; Zhang Z; Peng W; Shi D
    J Immunol Res; 2021; 2021():6439975. PubMed ID: 34541005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a circular RNA regulatory stemness-related gene pair signature for predicting prognosis and therapeutic response in colorectal cancer.
    Chen Q; Tang P; Huang H; Qiu X
    Front Immunol; 2022; 13():934124. PubMed ID: 35958575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of an immune prognostic signature in colorectal cancer.
    Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
    Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated analysis reveals a novel 5-fluorouracil resistance-based prognostic signature with promising implications for predicting the efficacy of chemotherapy and immunotherapy in patients with colorectal cancer.
    Hou Y; Zhang F; Zong J; Li T; Gan W; Lv S; Yan Z; Zeng Z; Yang L; Zhou M; Zhao W; Yang M
    Apoptosis; 2024 Aug; 29(7-8):1126-1144. PubMed ID: 38824480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Validation of the Glycolysis and Immune-related Gene Signature for Prognosis in Colorectal Cancer.
    Jiang M; Liu Y; Xu J; Xu Z; Ye T; Li S; Jiang C
    Anticancer Res; 2024 Jan; 44(1):117-131. PubMed ID: 38159970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immune landscape based prognostic signature predicts the immune status and immunotherapeutic responses of patients with colorectal cancer.
    Li M; Li W; Yang X; Wang H; Peng Y; Yin J; Lu Y; Liu L; Shang J; Zhao Q
    Life Sci; 2020 Nov; 261():118368. PubMed ID: 32888940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immune-related gene prognostic index for predicting prognosis in patients with colorectal cancer.
    Li C; Wirth U; Schardey J; Ehrlich-Treuenstätt VV; Bazhin AV; Werner J; Kühn F
    Front Immunol; 2023; 14():1156488. PubMed ID: 37483596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
    Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
    J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated single-cell and bulk RNA sequencing analysis identifies a cancer associated fibroblast-related signature for predicting prognosis and therapeutic responses in colorectal cancer.
    Zheng H; Liu H; Ge Y; Wang X
    Cancer Cell Int; 2021 Oct; 21(1):552. PubMed ID: 34670584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer.
    Zhang C; Zeng C; Xiong S; Zhao Z; Wu G
    Sci Rep; 2022 Nov; 12(1):18688. PubMed ID: 36333388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A signature based on 11 autophagy genes for prognosis prediction of colorectal cancer.
    Chen S; Wang Y; Wang B; Zhang L; Su Y; Xu M; Zhang M
    PLoS One; 2021; 16(10):e0258741. PubMed ID: 34699544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of endoplasmic reticulum stress in colorectal cancer for predicting prognosis and developing treatment options.
    Geng J; Guo Y; Xie M; Li Z; Wang P; Zhu D; Li J; Cui X
    Cancer Med; 2023 May; 12(10):12000-12017. PubMed ID: 36999888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
    Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
    Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer.
    Yang X; Weng X; Yang Y; Zhang M; Xiu Y; Peng W; Liao X; Xu M; Sun Y; Liu X
    Aging (Albany NY); 2021 Aug; 13(15):19486-19509. PubMed ID: 34341184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
    Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T
    Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a Novel Immune-Related mRNA Signature to Predict the Prognosis and Immune Characteristics of Human Colorectal Cancer.
    Li J; Han T; Wang X; Wang Y; Chen X; Chen W; Yang Q
    Front Genet; 2022; 13():851373. PubMed ID: 35401707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.